OakChart

Steris Plc

STEHealthcare·Medical Devices·Ireland·Large·NYSE·Nov 11 • 10:06 AM ET

254.36-2.76 (-1.07%)
2026-11-11 16:07 CET
Market cap
24,968.15 USD m
Revenue, TTM
6,165.90 USD m
Net income, TTM
827.00 USD m
Free cash flow, TTM
937.20 USD m
EPS diluted, TTM
8.43
P/E
30.18
Compare

Price

STE against its 20, 50 and 200-day averages
2050200beatmiss
200.00220.00240.00260.00911K1.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26STEclose 254.3620-day 235.7050-day 222.02200-day 224.15254.36

5.6% under 269.44 on 16 Jan 2026. Last 15 sessions, 16.7% high to low

Profile

STE
52-week range, 80% of the way up
195.14269.44

STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.

IndexS&P 500, RUI
Employees17937
IPOJun 01, 1992
Beta0.84
ATR, 14d6.62
Rel volume0.31
Short float2.25%
Insider own0.34%
Inst own100.88%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap24.70B
Enterprise Value26.23B
Income827.00M
Sales6.17B
Book/sh74.74
Cash/sh5.47
Dividend Est.2.69 (1.06%)
Dividend TTM2.58 (1.01%)
Dividend Ex-DateNov 17, 2026
Dividend Gr. 3/5Y10.16% 9.40%
Payout31.04%
Employees17937
IPOJun 01, 1992

Ratios

P/E30.18
Forward P/E20.59
PEG2.07
P/S4.01
P/B3.40
P/C46.51
P/FCF26.36
EV/EBITDA15.17
EV/Sales4.25
Quick Ratio1.44
Current Ratio2.05
Debt/Eq0.28
LT Debt/Eq0.24
Option/ShortYes / Yes

Earnings

EPS (ttm)8.43
EPS next Y12.35
EPS next Q2.80
EPS this Y12.27%
EPS next Y8.18%
EPS next 5Y9.93%
EPS past 3/5Y95.07% 11.37%
Sales past 3/5Y9.38% 13.82%
EPS Y/Y TTM19.88%
Sales Y/Y TTM8.13%
EPS Q/Q12.73%
Sales Q/Q8.79%
EarningsNov 04 AMC
EPS/Sales Surpr.9.68% 2.43%

Ownership

Insider Own0.34%
Insider Trans-3.33%
Inst Own100.88%
Inst Trans-0.97%
ROA7.83%
ROE11.59%
ROIC9.16%
Gross Margin45.23%
Oper. Margin20.02%
Profit Margin13.41%
SMA207.91%
SMA5014.57%
SMA20013.48%
Trades-

Technical

Shs Outstand97.10M
Shs Float96.78M
Short Float2.25%
Short Ratio3.07
Short Interest2.18M
52W High269.44 -5.60%
52W Low195.14 30.35%
Volatility3.67% 2.66%
ATR (14)6.62
RSI (14)71.27
Beta0.84
Rel Volume0.31
Avg Volume709.99K
Volume30,033

Performance

Perf Week2.60%
Perf Month16.80%
Perf Quarter7.75%
Perf Half Y20.49%
Perf YTD0.33%
Perf Year-4.63%
Perf 3Y27.61%
Perf 5Y9.87%
Perf 10Y292.47%
Recom2.00
Target Price275.17
Prev Close257.12
Price254.36
Change %-1.07%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 28, 2026InitiatedUUBSBuy$275+8.1%
Jul 15, 2025UpgradeMMorgan StanleyEqual-Weight → Overweight$276+8.5%
May 29, 2025InitiatedJJefferiesHold$263+3.4%
Oct 24, 2024UpgradePPiper SandlerNeutral → Overweight$230 → $260+2.2%
Feb 06, 2024ResumedKKeyBanc Capital MarketsOverweight$253-0.5%
May 30, 2023InitiatedMMorgan StanleyEqual-Weight$206-19.0%
Apr 14, 2023DowngradePPiper SandlerOverweight → Neutral$215 → $197-22.6%
Sep 23, 2022DowngradeNNeedhamBuy → Hold
Jul 14, 2022InitiatedPPiper SandlerOverweight$240-5.6%
Apr 07, 2022InitiatedWWolfe ResearchOutperform$275+8.1%

Peers

Mkt cap
TickerCompanyMkt cap
SHCSotera Health Co4.69B
SOLVSolventum Corp15.13B
MDLNMedline Inc55.03B
SYKStryker Corp120.56B
BAXBaxter International Inc13.55B
BDXBecton Dickinson & Co57.81B
FTVFortive Corp20.09B
TFXTeleflex Incorporated6.12B
ECLEcolab Inc85.63B
MLABMesa Laboratories Inc781.59M

Insider trading

latest 14 of 23
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sohi MohsenDirectorNov 10 '26Proposed Sale253.224,8931,239,012Nov 10 04:15 PM
Breeden Richard CDirectorAug 18 '26Proposed Sale231.904,110953,114Aug 18 05:25 PM
Sohi MohsenDirectorAug 12 '26Option Exercise86.234,058349,92128,363Aug 12 04:33 PM
Sohi MohsenDirectorAug 12 '26Sale235.784,058956,79524,305Aug 12 04:33 PM
Sohi MohsenDirectorAug 12 '26Proposed Sale235.784,058956,779Aug 12 04:06 PM
Zangerle John AdamSr. VP, Gen Counsel, and Sec.Jun 15 '26Sale209.281,419296,96835,259Jun 16 04:31 PM
Zangerle John AdamOfficerJun 15 '26Proposed Sale209.281,419296,968Jun 15 04:06 PM
Carestio Daniel APresident and CEOJun 04 '26Sale214.643,054655,51165,021Jun 08 04:31 PM
Carestio Daniel APresident and CEOJun 05 '26Sale212.001,374291,28863,647Jun 08 04:31 PM
Carestio Daniel AOfficerJun 05 '26Proposed Sale212.001,374291,288Jun 05 04:06 PM
Breeden Richard CDirectorJun 02 '26Option Exercise71.403,781269,96340,445Jun 04 04:31 PM
Breeden Richard CDirectorJun 02 '26Sale209.511,481310,28438,964Jun 04 04:31 PM
Carestio Daniel AOfficerJun 04 '26Proposed Sale214.643,054655,511Jun 04 04:13 PM
Breeden Richard CDirectorJun 02 '26Proposed Sale209.511,481310,285Jun 02 04:18 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
SDYState Street SPDR S&P Dividend ETFAUM: 22.68B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B

News

latest 14 of 206
  • STERIS Beats And Raises, But Tariff Refunds And One Big Life Sciences Order Flatter A Quarter With Softer Margins Underneath (Earnings Whispers)
  • Steris: Fiscal Q2 Earnings Snapshot (Associated Press) +7.16%
  • STERIS Announces Financial Results for Fiscal 2027 Second Quarter (GlobeNewswire)
  • Bracco announces $230 million Sanford investment, 200 jobs (The Sanford Herald, N.C.)
  • STERIS Announces Dividend of $0.69 per share (GlobeNewswire)
  • Loading…
  • STERIS Needs Its Fiscal Second Quarter To Set Up A Back-Loaded Year (Earnings Whispers)
  • STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026 (GlobeNewswire)
  • Steris inks $2.1B Xodus buyout to expand consumables portfolio (MedTech Dive)
  • Steris outlays $2.1bn to acquire Xodus Medical (Medical Device Network)
  • Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE) (PR Newswire)
  • Steris to Acquire Xodus Medical for $2.1 Billion (The Wall Street Journal)
  • STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety (GlobeNewswire)
  • STERIS to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-042.9402.6812.1901,6001,5627
2026Q12026-08-052.5902.4952.0441,5001,4957
2025Q42026-05-112.8302.8492.2391,5881,5957
2025Q32026-02-042.5302.5331.9561,4961,4818
2025Q22025-11-052.4702.3511.9421,5001,4318
2025Q12025-08-062.3402.2641.7961,4001,3638
2024Q42025-05-142.7402.5991.5341,4811,4697
2024Q32025-02-052.3202.3211.7541,4001,3827
2024Q22024-11-062.1402.1231.5121,3291,3307
2024Q12024-08-062.1401.9771.4631,2801,2727
2023Q42024-05-082.4102.350-0.0141,4191,4117
2023Q32024-02-072.2202.1691.4171,3961,3497
2023Q22023-11-072.0302.0031.1601,3421,2996
2023Q12023-08-012.0001.8601.2451,2801,2077
2022Q42023-05-102.3002.1481.8801,3851,2736
2022Q32023-02-082.0202.1931.2361,2161,2736

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY4.1504.1303.3942,6202,607
2018FY4.8904.7863.5582,7832,753
2019FY5.6405.5734.7603,0293,007
2020FY6.1706.2974.6263,1083,108
2021FY7.9207.8982.4804,5854,548
2022FY8.2008.0481.0684,9584,846
2023FY8.2008.6043.8075,1395,446
2024FY9.3309.1016.3455,4605,450
2025FY10.17010.1977.9305,9365,941
2026FY-11.418--6,375
2027FY-12.352--6,770
2028FY-13.509--7,208

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-057021,6001,5901,612
2026Q3S2026-11-047001,6121,6041,625
2026Q3S2026-10-207001,6121,6041,625
2026Q3S2026-10-157101,6121,6041,625
2026Q3S2026-08-188101,6121,6041,625
2026Q3S2026-08-148201,6121,6041,625
2026Q3S2026-08-108201,6121,6071,625
2026Q3S2026-08-078201,6121,6071,625
2026Q3S2026-08-068201,6111,6041,625
2026Q3S2026-07-288101,6081,5901,621
2026Q3S2026-07-267101,6071,5901,621
2026Q3S2026-06-047501,6071,5901,621
2026Q3S2026-06-036401,6071,5901,621
2026Q3S2026-05-126401,6071,5901,621

Estimate history

EPS, annual3.3943.5584.764.6262.481.0683.8076.3457.9268.4287
Period201720182019202020212022202320242025TTM
EPS, quarterly1.5121.7541.5341.7961.9421.9562.2392.0442.19
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual2619.9962782.173030.8953107.5194585.0644536.2665138.7015459.5155935.96165.9
Period201720182019202020212022202320242025TTM
Sales, quarterly1328.9121370.571480.5311391.11460.31496.21588.41492.71588.6
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual84.74784.51784.92485.353100.06798.62998.88398.30197.897.1
Period201720182019202020212022202320242025MRQ
Shares, quarterly98.70898.24598.30198.598.198.197.897.597.1
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue6,165.905,935.905,459.525,138.704,536.274,585.063,107.523,030.892,782.17
Cost of Goods Sold Incl. D&A3,376.803,274.903,040.322,900.612,551.912,572.621,765.311,707.771,597.46
Gross Profit2,789.102,661.002,419.202,238.091,984.362,012.441,342.211,323.131,184.71
Selling, General and Administrative Excl. Other1,554.401,513.901,432.691,330.251,173.201,390.46734.27768.63726.52
Research and Development118.40112.90107.65103.6898.4887.9466.3365.5563.04
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,234.701,147.10986.51907.84811.16621.98607.94554.49458.19
Interest Expense57.0060.7086.26144.35107.9689.5937.1840.2845.02
Unusual Expense64.8045.10118.9669.79511.87224.0756.9519.2648.10
Net Income Before Taxes1,123.801,047.30796.21702.81680.27314.50517.53498.75369.47
Income Taxes294.10262.20184.65149.53124.0771.63120.6690.8964.39
Consolidated Net Income829.90785.10611.56553.28556.20242.87396.87407.86305.08
Net Income From Continuing Operations827.00782.30610.12551.44557.41243.89397.40407.66304.05
Net Income827.00782.30628.64378.24107.03243.89397.40407.66304.05
EPS (Recurring)8.948.257.194.304.644.085.094.923.95
EPS (Basic, Before Extraordinaries)8.467.976.383.831.072.504.664.813.60
EPS (Diluted)8.437.936.353.811.072.484.634.763.56
EBITDA1,729.501,633.601,462.721,473.091,364.061,175.08827.18751.73684.11
Non-Operating Income (Expense)10.906.0014.929.11488.936.183.723.804.39
Other After Tax Adjustments0.100.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-48.7445.3444.6630.7743.3646.8030.7030.83
Price To Earnings Ratio30.5130.5148.0639.43179.20100.9741.1829.4140.69
Price To Sales Ratio3.323.684.114.354.235.185.273.953.93
Gross Margin45.2344.8344.3143.5543.7443.8943.1943.6542.58
Operating Margin20.0219.3218.0717.6717.8813.5719.5618.2916.47
Net Margin13.4113.1811.517.362.365.3212.7913.4510.93
Shares Outstanding97.1097.8098.3098.8898.63100.0785.3584.9284.52
Market Capitalization24,968.1524,968.1522,268.5422,215.3618,991.1424,207.7016,257.9811,871.2810,827.50

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue1,588.601,492.701,588.401,496.201,460.301,391.101,480.531,370.57
Cost of Goods Sold Incl. D&A871.50808.50855.70841.10815.40762.90825.08760.58
Gross Profit717.10684.20732.70655.10644.90628.20655.45609.99
Selling, General and Administrative Excl. Other397.50399.90378.80378.20376.00381.30361.37359.37
Research and Development31.5028.6028.8029.5028.2026.4027.6927.36
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income319.60284.30353.90276.90268.90246.90294.09250.62
Interest Expense11.2015.8015.1014.9014.9015.9017.1119.09
Unusual Expense25.40-1.3037.103.603.001.0076.166.11
Net Income Before Taxes288.00273.50304.50257.80253.10231.90197.31228.75
Income Taxes73.9072.5084.2063.5060.6053.9050.4555.38
Consolidated Net Income214.10201.00220.40194.40192.50178.00146.86173.36
Net Income From Continuing Operations213.70200.10220.30192.90191.90177.40146.46173.61
Net Income213.70200.10220.30192.90191.90177.40151.46173.53
EPS (Recurring)2.372.032.501.981.961.802.071.80
EPS (Basic, Before Extraordinaries)2.202.052.251.961.951.801.541.76
EPS (Diluted)2.192.042.241.961.941.801.531.75
EBITDA445.20408.10477.30398.90390.60366.30416.44376.54
Non-Operating Income (Expense)4.903.602.80-0.402.101.90-3.513.32
Other After Tax Adjustments0.000.000.000.100.000.000.000.00
Stock Option Compensation Expense20.7811.14-24.6522.7516.75-12.34
Price To Earnings Ratio30.5126.5430.5936.0937.5238.3548.0646.95
Price To Sales Ratio3.323.413.674.294.294.264.103.77
Gross Margin45.1445.8446.1343.7844.1645.1644.2744.51
Operating Margin20.1219.0522.2818.5118.4117.7519.8618.29
Net Margin13.4513.4113.8712.8913.1412.7510.2312.66
Shares Outstanding97.1097.5097.8098.1098.1098.5098.3098.25
Market Capitalization24,968.1520,521.6721,687.3224,882.2324,370.5123,630.6822,268.5420,290.27

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments439.60171.70207.02208.36348.32220.53319.58220.63201.53
Short Term Receivables1,092.801,043.961,008.32864.99799.04609.41586.48564.83528.07
Inventories631.80581.33674.53604.41575.00315.07263.54208.24205.73
Other Current Assets230.40203.77979.25333.69156.6466.7554.4360.0354.33
Total Current Assets2,394.602,000.772,869.122,011.441,879.001,211.751,224.041,053.73989.66
Net Property, Plant & Equipment2,316.402,112.931,938.381,799.331,741.061,385.541,243.691,031.581,010.52
Total Investments and Advances45.5014.300.000.000.000.000.000.000.00
Long-Term Note Receivable----8.138.578.07--
Intangible Assets5,814.805,950.076,189.995,955.927,732.883,924.452,921.562,927.543,160.76
Other Assets165.9068.7566.201,055.1562.5344.1543.5160.2139.39
Total Assets10,737.2010,146.8111,063.7010,821.8411,423.596,574.475,440.875,073.075,200.33
Short Term Debt Incl. Current Port. of LT Debt154.70159.20117.1890.06179.3522.7719.810.000.00
Accounts Payable338.80280.77251.72264.17225.74156.95149.34152.91135.87
Income Tax Payable28.6021.4613.6440.4826.8727.5614.0115.460.38
Other Current Liabilities622.90560.75548.59467.14490.26370.63320.44296.82262.22
Total Current Liabilities1,145.001,022.17931.13861.84922.22577.92503.61465.20398.46
Long Term Debt1,932.402,043.343,265.993,158.213,100.541,780.211,264.631,183.231,316.00
Provision for Risks Charges49.5047.3044.0044.8642.0444.2250.4955.9769.67
Deferred Tax Liabilities390.70403.65481.84619.77783.52239.16164.94153.35159.97
Other Liabilities22.4014.5925.3949.9830.6341.4938.9829.5338.93
Total Liabilities3,540.003,531.054,748.354,734.674,878.962,683.002,022.661,887.271,983.03
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.01
Common Equity7,183.606,603.406,302.166,077.206,532.363,880.993,405.363,177.813,205.95
Total Shareholders Equity7,183.606,603.406,302.166,077.206,532.363,880.993,405.363,177.813,205.96
Accumulated Minority Interest13.6012.3513.189.9712.2810.4812.857.9911.34
Total Equity7,197.206,615.766,315.356,087.176,544.643,891.473,418.213,185.803,217.30
Total Liabilities & Stockholders Equity10,737.2010,146.8111,063.7010,821.8411,423.596,574.475,440.875,073.075,200.33
Book Value Per Share73.4567.1863.7361.6265.2845.4740.1037.6037.83
Tangible Book Value Per Share14.006.651.131.23-12.00-0.515.702.960.53
Full-Time Employees17,93717,78718,17917,10016,42212,77013,00012,00012,000
Price to Book Ratio3.443.473.463.103.704.193.503.492.55
Return on Assets7.495.755.045.012.716.627.755.925.75
Return on Equity11.359.468.918.844.6810.9312.389.539.69
Return on Invested Capital8.587.273.951.162.537.028.736.976.43
Quick Ratio1.541.392.361.631.411.551.911.821.97
Current Ratio2.091.963.082.332.042.102.432.272.48

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income829.80785.10616.07380.08105.81242.87396.87407.86305.08
Depreciation494.80486.50476.21565.24552.90553.10219.24197.24225.92
Other Funds (Non Cash)50.1059.6063.52305.44534.17127.2637.4424.554.63
Funds from Operations1,357.801,314.301,079.261,119.351,006.97816.62657.79639.09529.12
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-68.1027.1066.51-146.08-250.02-149.2819.01-49.819.90
Cash from Operating Activities1,289.701,341.401,145.77973.27756.95667.34676.79589.28539.02
Capital Expenditures-352.50-369.00-370.09-360.33-361.97-287.56-239.26-214.52-189.72
Net Assets From Acquisitions-21.10-20.10-54.14-546.26-42.57-550.45-909.19-109.81-13.31
Sale of Fixed Assets and Businesses10.6010.60826.2819.8321.21175.123.3510.648.04
Purchase or Sale of Investments-137.20-134.00-10.752.380.000.00-4.400.00-4.96
Purchase of Investments-137.20-134.00-10.75-1.500.000.00-4.400.00-4.96
Sale Or Maturity of Investments0.000.000.003.880.000.000.000.00-
Other Uses0.000.000.000.000.000.00-2.390.00-13.29
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-500.30-512.50391.31-884.37-383.33-662.89-1,151.90-313.69-213.22
Cash Dividends Paid-252.10-241.80-219.88-200.57-183.50-163.17-133.84-123.03-112.50
Change in Capital Stock-318.50-202.60-185.85-1.29-306.74-45.7112.08-16.51-68.39
Repurchase of Common Pref Stock-340.30-235.50-211.32-11.77-308.56-55.78-14.65-51.24-81.49
Sale of Common Pref Stock21.8032.9025.4710.471.8310.0726.7334.7313.11
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-122.00-1,164.43121.49-6.22372.18484.54-26.50-112.09
Change in Long Term Debt0.00-122.00-1,164.43121.49-6.22372.18484.54-26.50-112.09
Issuance of Long Term Debt3.003.000.00181.49241.662,000.00550.000.000.00
Reduction of Long Term Debt-3.00-125.00-1,164.43-60.00-247.88-1,627.82-65.46-26.50-112.09
Net Financing Active Other Cash Flow-2.30-1.80-2.42-7.80-2.27-33.68-6.57-1.87-1.33
Other Financing Activities Uses-2.30-1.80-2.42-7.80-2.27-33.68-6.57-1.87-1.33
Cash from Financing Activities-572.90-568.20-1,572.58-88.18-498.72129.63356.21-167.91-294.30
Exchange Rate Effect-4.407.200.18-2.06-14.86-6.2919.85-8.73-12.39
Net Change in Cash212.10267.90-35.32-1.34-139.96127.79-99.0598.9519.10
Free Cash Flow937.20972.40775.68612.95394.98379.78437.53374.76349.30
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow29.9229.8740.4054.1790.67109.7553.8847.6246.21
Deferred Taxes & Investment Tax Credit--16.90-76.55-131.41-185.91-106.624.249.44-6.51

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments531.10482.30439.60423.70319.20279.70
Short Term Receivables1,005.201,013.201,092.80990.60947.30947.10
Inventories737.00712.10631.80673.50658.50641.20
Other Current Assets205.90238.20230.40198.40181.30189.80
Total Current Assets2,479.202,445.802,394.602,286.202,106.302,057.80
Net Property, Plant & Equipment2,343.602,322.502,316.402,288.102,252.102,218.30
Total Investments and Advances50.5050.5045.500.000.000.00
Intangible Assets5,675.805,752.705,814.805,923.505,964.306,040.30
Other Assets164.50164.60165.9093.6087.9088.60
Total Assets10,713.6010,736.1010,737.2010,591.4010,410.7010,405.00
Short Term Debt Incl. Current Port. of LT Debt280.30279.00154.7034.4035.3035.30
Accounts Payable334.20344.10338.80285.10308.90300.90
Income Tax Payable55.5086.5028.609.9016.9064.70
Other Current Liabilities537.80573.70622.90592.90527.80525.70
Total Current Liabilities1,207.801,283.301,145.00922.30888.90926.60
Long Term Debt1,769.301,765.501,932.402,019.302,023.302,033.50
Provision for Risks Charges49.9049.9049.5049.1048.6048.60
Deferred Tax Liabilities389.70390.80390.70414.50412.00411.40
Other Liabilities25.2025.3022.4018.3015.3015.10
Total Liabilities3,441.903,514.803,540.003,423.503,388.103,435.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,257.307,206.707,183.607,154.507,009.106,957.00
Total Shareholders Equity7,257.307,206.707,183.607,154.507,009.106,957.00
Accumulated Minority Interest14.4014.5013.6013.4013.5012.90
Total Equity7,271.707,221.207,197.207,167.907,022.606,969.90
Total Liabilities & Stockholders Equity10,713.6010,736.0010,737.2010,591.4010,410.7010,405.10
Book Value Per Share74.7473.9173.4572.9371.4570.63
Tangible Book Value Per Share16.2914.9114.0012.5510.659.31
Full-Time Employees--17,937---
Price to Book Ratio3.442.873.033.553.503.58
Return on Assets7.837.627.496.886.686.31
Return on Equity11.5911.3711.3510.4410.149.73
Return on Invested Capital2.372.232.422.102.121.97
Quick Ratio1.441.351.541.751.631.53
Current Ratio2.051.912.092.482.372.22

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income214.10201.00220.30194.40192.40178.00
Depreciation125.60123.80123.40122.00121.70119.40
Other Funds (Non Cash)13.3024.00-5.1017.9020.4026.40
Funds from Operations352.30349.40321.90334.20334.40323.80
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-63.4017.8013.50-36.00-46.6096.20
Cash from Operating Activities288.90367.20335.40298.20287.80420.00
Capital Expenditures-76.10-87.50-90.20-98.70-86.50-93.60
Net Assets From Acquisitions0.00-16.000.00-5.100.00-15.00
Sale of Fixed Assets and Businesses0.000.000.2010.40-0.100.10
Purchase or Sale of Investments0.00-5.00-127.20-5.00-1.800.00
Purchase of Investments0.00-5.00-127.20-5.00-1.800.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-76.10-108.50-217.20-98.50-88.30-108.50
Cash Dividends Paid-67.00-61.40-61.80-61.90-61.90-56.20
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-95.90-114.20-73.70-34.70-92.90-1.30
Repurchase of Common Pref Stock-100.40-115.50-74.30-50.10-100.50-10.60
Sale of Common Pref Stock4.501.300.6015.407.609.30
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-37.8037.800.00-4.30-155.50
Change in Long Term Debt0.00-37.8037.800.00-4.30-155.50
Issuance of Long Term Debt0.000.003.000.000.000.00
Reduction of Long Term Debt0.00-37.8034.800.00-4.30-155.50
Net Financing Active Other Cash Flow-0.60-0.10-0.20-1.40-0.10-0.10
Other Financing Activities Uses-0.60-0.10-0.10-1.50-0.10-0.10
Cash from Financing Activities-163.50-213.50-97.90-98.00-159.20-213.10
Exchange Rate Effect-0.60-2.30-4.402.90-0.909.60
Net Change in Cash48.8042.8015.90104.6039.40108.00
Free Cash Flow212.80279.70245.20199.50201.30326.40
Price to Free Cash Flow29.9230.3729.7836.7033.5534.81

Revenue breakdown

Capital equipment revenues2024: 1.19B 2025: 1.25B
Consolidation, Policy2024: 100.00K 2025: 100.00K
Consumable revenues2024: 1.68B 2025: 1.80B
Service revenues2024: 2.59B 2025: 2.88B
Consolidation, Policy2025: -100.00K
Ireland2024: 107.30M 2025: 108.50M
Other foreign locations2024: 1.34B 2025: 1.49B
United States2024: 4.01B 2025: 4.33B
Applied Sterilization Technologies2024: 1.04B 2025: 1.14B
Consolidation, Policy2024: -100.00K
Healthcare2024: 3.88B 2025: 4.21B
Life Science2024: 542.30M 2025: 588.80M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.25%2.2M96.8M687.11K
2026-10-152.47%2.4M97.2M678.24K
2026-09-302.94%2.9M97.2M689.98K
2026-09-152.87%2.8M97.2M739.54K
2026-08-312.51%2.4M97.2M767.26K
2026-08-142.38%2.3M97.2M811.54K
2026-07-313.25%3.2M97.1M822.21K
2026-07-152.51%2.4M97.1M821.55K
2026-06-302.41%2.3M97.1M791.67K
2026-06-152.07%2.0M97.1M758.68K
2026-05-291.86%1.8M97.3M806.19K
2026-05-152.22%2.2M97.8M820.14K
2026-04-301.91%1.9M97.8M870.37K
2026-04-151.66%1.6M97.8M847.83K
2026-03-311.87%1.8M97.8M831.56K
2026-03-131.80%1.8M97.8M784.95K
2026-02-271.78%1.7M97.8M702.73K
2026-02-131.85%1.8M97.8M666.84K
2026-01-301.60%1.6M97.8M616.39K
2026-01-151.30%1.3M97.8M636.37K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call135119122.30.002.5150.000.000.992-0.0910.009
call140114117.30.002.3900.000.000.992-0.0910.009
call145109.3112.60.002.2710.000.000.991-0.0910.009
call150104107.40.002.1800.000.000.991-0.0910.010
call15599.00102.80.002.1160.000.000.990-0.0910.010
call16094.0097.300.001.9280.000.000.990-0.0910.011
call16589.3092.300.001.8210.000.000.989-0.0900.011
call17084.0087.400.001.7400.000.000.988-0.0900.012
call17579.0082.400.001.6380.000.000.988-0.0900.013
call18074.0077.200.001.4930.000.000.987-0.0890.013
call18569.0072.200.001.3970.000.000.986-0.0890.014
call19064.0067.200.001.3030.000.000.961-0.2210.034
call19559.0062.300.001.2300.000.000.958-0.2180.036
call20054.3057.300.001.1380.000.000.955-0.2140.038
call21044.3047.4022.050.97311.000.000.947-0.2050.043
call22034.0037.407.570.9216.000.000.935-0.1930.051
call23024.0027.3014.050.60614.000.000.919-0.1800.060
call24014.6017.908.300.48410.000.000.783-0.3680.118
call2506.109.5011.400.39019.000.000.643-0.3700.150
call2601.403.803.000.3445540.000.396-0.3320.155
call2700.002.801.710.4742030.000.265-0.3670.132
call2800.000.750.000.4210.000.000.102-0.1720.072
call2900.000.750.000.5390.000.000.079-0.1780.059
call3000.000.750.000.6480.000.000.068-0.1900.053
call3100.000.750.000.7490.000.000.060-0.2000.048
call3200.000.750.000.8440.000.000.055-0.2080.045
put1350.002.150.001.7790.000.00-0.008-0.0840.009
put1400.002.150.001.6860.000.00-0.008-0.0830.009
put1450.002.150.001.5970.000.00-0.009-0.0820.009
put1500.002.150.001.5110.000.00-0.009-0.0820.010
put1550.002.150.001.4200.000.00-0.010-0.0810.010
put1600.001.950.001.3390.000.00-0.010-0.0800.011
put1650.002.150.001.2600.000.00-0.011-0.0790.011
put1700.001.750.701.1831.000.00-0.011-0.0780.012
put1750.000.750.001.1150.000.00-0.012-0.0780.013
put1800.000.750.001.0470.000.00-0.013-0.0770.013
put1850.000.200.051.30921.000.00-0.050-0.2890.043
put1900.000.750.501.1273.000.00-0.038-0.2080.034
put1950.000.750.001.0450.000.00-0.041-0.2040.036
put2000.000.750.100.9655090.00-0.044-0.2000.038
put2100.000.751.040.8079.000.00-0.052-0.1900.043
put2200.000.751.170.6523700.00-0.063-0.1780.050
put2300.000.752.900.5001150.00-0.079-0.1620.060
put2400.003.001.600.5663750.00-0.206-0.3320.115
put2502.104.805.450.46153.000.00-0.356-0.3500.150
put2606.509.000.000.4120.000.00-0.597-0.3080.156
put27014.0016.700.000.4570.000.00-0.752-0.3170.128
put28023.4026.400.000.5910.000.00-0.902-0.1430.070
put29033.2036.100.000.6990.000.00-0.922-0.1530.059
put30043.3046.000.000.8120.000.00-0.932-0.1640.053
put31053.3056.500.000.9920.000.00-0.940-0.1730.048
put32063.2066.500.001.1050.000.00-0.945-0.1800.044

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-11-06424B5SEC
2026-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-138-KCurrent report2026-10-11SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-07-31SEC
2026-08-068-K/A2026-05-07SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-1611-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-06-11ARSAnnual report to security holders. 2026-03-31SEC
2026-06-11DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-11DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-07-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800956.80K1
2026-070000
2026-06001.55M4
2026-050000
2026-040000
2026-0300734.88K1
2026-020000
2026-010000
2025-120000
2025-11006.59M3

Institutional holders

Manager% owned
BlackRock, Inc.9.05%
VANGUARD CAPITAL MANAGEMENT LLC6.57%
STATE STREET CORP5.21%
VANGUARD PORTFOLIO MANAGEMENT LLC5.13%
MORGAN STANLEY4.05%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.90%
WELLINGTON MANAGEMENT GROUP LLP3.59%
Orbis Allan Gray Ltd2.75%
GEODE CAPITAL MANAGEMENT, LLC2.72%
GENERATION INVESTMENT MANAGEMENT LLP2.34%

Funds

Fund% owned
Baird Aggregate Bond Fund7.70%
Baird Core Plus Bond Fund7.70%
State Street(R) SPDR(R) Portfolio Intermediate Term Corporate Bond ETF4.16%
iShares ESG Aware 1-5 Year USD Corporate Bond ETF3.98%
iShares Core U.S. Aggregate Bond ETF3.91%
iShares iBonds Dec 2031 Term Corporate ETF3.85%
iShares 1-5 Year Investment Grade Corporate Bond ETF3.78%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.20%
VANGUARD 500 INDEX FUND2.61%
iShares ESG Aware USD Corporate Bond ETF2.26%

OakChart. STE. Cached 15 minutes.